Company Filing History:
Years Active: 2003-2007
Title: Silvia Mandel: Innovator in Placental Protein Research
Introduction
Silvia Mandel is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of biomedical research, particularly in the study of placental proteins. With a total of 2 patents, her work has implications for pregnancy-related diagnostics and treatments.
Latest Patents
Mandel's latest patents focus on Placental Protein 13 (PP13). The full amino acid and DNA sequences of PP13 are disclosed in her patents. Additionally, various PP13-derived peptide fragments and a recombinant method for the production of PP13 are described. This protein may be utilized in screening and diagnostic methods for pregnancy-related complications, showcasing its potential impact on maternal and fetal health.
Career Highlights
Throughout her career, Silvia Mandel has worked with notable organizations such as Diagnostic Technologies Ltd. and Technion Research & Development Foundation Limited. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Mandel has collaborated with esteemed colleagues, including Arie Admon and Yoav Paltieli. These partnerships have enriched her research and expanded the scope of her work in the field of placental proteins.
Conclusion
Silvia Mandel's innovative research on Placental Protein 13 positions her as a key figure in the advancement of pregnancy-related diagnostics. Her contributions are vital for improving maternal and fetal health outcomes.